4.5 Article

The epidemiology of paediatric Mycoplasma pneumoniae pneumonia in North China: 2006 to 2016

Journal

EPIDEMIOLOGY AND INFECTION
Volume 147, Issue -, Pages -

Publisher

CAMBRIDGE UNIV PRESS
DOI: 10.1017/S0950268819000839

Keywords

Epidemiology; Mycoplasma; paediatrics; pneumonia

Funding

  1. Capital's Funds for Health Improvement and Research [2014-1-2094]
  2. Capital Characteristic Clinic Project [Z171100001017081]

Ask authors/readers for more resources

Paediatric Mycoplasma pneumoniae pneumonia (MPP) is a major cause of communityacquired pneumonia in China. Data on epidemiology of paediatric MPP from China are little known. This study retrospectively collected data from June 2006 to June 2016 in Beijing Children's Hospital, Capital Medical University of North China and aims to explore the epidemiological features of paediatric MPP and severe MPP (SMPP) in North China during the past 10 years. A total of 27 498 paediatric patients with pneumonia were enrolled. Among them, 37.5% of paediatric patients had MPP. In this area, an epidemic took place every 23 years at the peak, and the positive rate of MPP increased during these peak years over time. The peak age of MPP was between the ages of 6 and 10 years, accounting for 75.2%, significantly more compared with other age groups (.2 = 1384.1, P < 0.0001). The epidemics peaked in September, October and November (.2 = 904.9, P < 0.0001). Additionally, 13.0% of MPP paediatric patients were SMPP, but over time, the rate of SMPP increased, reaching 42.6% in 2016. The mean age of paediatric patients with SMPP (6.7 +/- 3.0 years old) was younger than that of patients with non-SMPP (7.4 +/- 3.2 years old) (t = 3.60, P = 0.0001). The prevalence of MPP and SMPP is common in China, especially in children from 6 to 10 years old. Paediatric patients with SMPP tend to be younger than those with nonSMPP. MPP outbreaks occur every 2-3 years in North China. September, October and November are the peak months, unlike in South China. Understanding the epidemiological characteristics of paediatric MPP can contribute to timely treatment and diagnosis, and may improve the prognosis of children with SMPP.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available